OPC Pharmaceutical Joint Stock Co (coded OPC) lately announced earning accumulative revenue of 334 billion dong, surpassing 45.2 percent of the year plan and pre-tax profit of 61 billion dong, equal to 148.8 percent of the year plan.
It’s estimated that in 2009 the company will gain 360 billion dong of total revenue and 65 billion dong of profit.
The company planned to start construction work on OPC pharmaceutical plant with GMP WHO standards in Binh Duong province. The total investment capital for the project was posted at about 160 billion dong. The plant was expected to start operation in early 2012 with doubled designed capacity in comparison with the company’s current one.
After December 21 trading session, price of OPC-coded shares increased by 1,000 dong to 52,000 dong per share with 10,840 units being transferred.